AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)
Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –
AtriCure total assets
Total assets on the balance sheet at the end of each period.
AtriCure's total assets was $676.64M at Jun 30, 2026. For fiscal 2025 it was $654.18M, up 7.4% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $714.54M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $654.18M | +7.4% |
| FY2024 | Dec 31, 2024 | $609.33M | -0.7% |
| FY2023 | Dec 31, 2023 | $613.93M | +4.9% |
| FY2022 | Dec 31, 2022 | $585.45M | -4.9% |
| FY2021 | Dec 31, 2021 | $615.31M | -13.9% |
| FY2020 | Dec 31, 2020 | $714.54M | +28.1% |
| FY2019 | Dec 31, 2019 | $557.88M | +56.4% |
| FY2018 | Dec 31, 2018 | $356.76M | +33.3% |
| FY2017 | Dec 31, 2017 | $267.70M | -3.2% |
| FY2016 | Dec 31, 2016 | $276.42M | +1.2% |
| FY2015 | Dec 31, 2015 | $273.09M | +72.4% |
| FY2014 | Dec 31, 2014 | $158.40M | +41.5% |
| FY2013 | Dec 31, 2013 | $111.95M | +245.2% |
| FY2012 | Dec 31, 2012 | $32.43M | -4.2% |
| FY2011 | Dec 31, 2011 | $33.86M | +0.4% |
| FY2010 | Dec 31, 2010 | $33.72M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $676.64M | +11.1% |
| Q1 FY2026 | Mar 31, 2026 | $643.99M | +8.8% |
| Q4 FY2025 | Dec 31, 2025 | $654.18M | +7.4% |
| Q3 FY2025 | Sep 30, 2025 | $635.44M | +3.3% |
| Q2 FY2025 | Jun 30, 2025 | $608.85M | +1.9% |
| Q1 FY2025 | Mar 31, 2025 | $591.63M | +0.0% |
| Q4 FY2024 | Dec 31, 2024 | $609.33M | -0.7% |
| Q3 FY2024 | Sep 30, 2024 | $615.07M | +2.5% |
| Q2 FY2024 | Jun 30, 2024 | $597.27M | +0.5% |
| Q1 FY2024 | Mar 31, 2024 | $591.63M | +1.5% |
| Q4 FY2023 | Dec 31, 2023 | $613.93M | +4.9% |
| Q3 FY2023 | Sep 30, 2023 | $600.27M | +3.2% |
| Q2 FY2023 | Jun 30, 2023 | $594.17M | +1.2% |
| Q1 FY2023 | Mar 31, 2023 | $583.10M | -0.3% |
| Q4 FY2022 | Dec 31, 2022 | $585.45M | -4.9% |
| Q3 FY2022 | Sep 30, 2022 | $581.91M | -5.1% |
| Q2 FY2022 | Jun 30, 2022 | $587.39M | -16.2% |
| Q1 FY2022 | Mar 31, 2022 | $584.98M | -16.4% |
| Q4 FY2021 | Dec 31, 2021 | $615.31M | -13.9% |
| Q3 FY2021 | Sep 30, 2021 | $612.97M | -13.4% |
| Q2 FY2021 | Jun 30, 2021 | $701.08M | -0.4% |
| Q1 FY2021 | Mar 31, 2021 | $699.90M | +32.6% |
| Q4 FY2020 | Dec 31, 2020 | $714.54M | +28.1% |
| Q3 FY2020 | Sep 30, 2020 | $707.80M | +26.2% |
| Q2 FY2020 | Jun 30, 2020 | $704.23M | +105.2% |
| Q1 FY2020 | Mar 31, 2020 | $527.73M | +56.0% |
| Q4 FY2019 | Dec 31, 2019 | $557.88M | +56.4% |
| Q3 FY2019 | Sep 30, 2019 | $560.76M | +106.2% |
| Q2 FY2019 | Jun 30, 2019 | $343.12M | +26.7% |
| Q1 FY2019 | Mar 31, 2019 | $338.36M | +25.5% |
| Q4 FY2018 | Dec 31, 2018 | $356.76M | +33.3% |
| Q3 FY2018 | Sep 30, 2018 | $271.96M | +1.3% |
| Q2 FY2018 | Jun 30, 2018 | $270.85M | +0.9% |
| Q1 FY2018 | Mar 31, 2018 | $269.70M | +1.2% |
| Q4 FY2017 | Dec 31, 2017 | $267.70M | -3.2% |
| Q3 FY2017 | Sep 30, 2017 | $268.45M | -3.9% |
| Q2 FY2017 | Jun 30, 2017 | $268.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $266.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $276.42M | – |
| Q3 FY2016 | Sep 30, 2016 | $279.32M | – |
See a number that looks wrong?